Underuse of Esophagectomy as Treatment for Resectable Esophageal Cancer

Abstract

There seems to be significant underuse of esophagectomy as treatment for potentially resectable stage I, II, and III esophageal cancers across all patient groups. In nonwhite and low socioeconomic patient cohorts, the underuse is even more pronounced.